A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Translational Research Laboratory Bookmark and Share

Translational Research Laboratory

The Translational Research Laboratory (TRL) at City of Hope is under the direct supervision of Yen Yun, M.D., Ph.D., Associate Director for Translational Research, City of Hope Comprehensive Cancer Center and, Professor and Chair of the Department ofMolecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Prices and availability vary. PleaseContact Usfor current information.
 
If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Translational Research Laboratory

Translational Research Laboratory

The Translational Research Laboratory (TRL) at City of Hope is under the direct supervision of Yen Yun, M.D., Ph.D., Associate Director for Translational Research, City of Hope Comprehensive Cancer Center and, Professor and Chair of the Department ofMolecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Pricing

Prices and availability vary. PleaseContact Usfor current information.
 
If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Translational Research Team

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...
  • Cancer treatment can take a toll on the mouth, even if a patient’s cancer has nothing to do with the head or throat, leading to a dry mouth, or a very sore mouth, and making it difficult to swallow or eat. Here’s some advice from the National Cancer Institute (NCI)  on how to ease cancer-related dis...